NDC 0078-1000

LEQVIO

Inclisiran

LEQVIO is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Novartis Pharmaceuticals Corporation. The primary component is Inclisiran Sodium.

• Product ID: 0078-1000_171e003a-8f8e-402e-b79c-fbca7d057373
• NDC: 0078-1000
• Product Type: Human Prescription Drug
• Proprietary Name: LEQVIO
• Generic Name: Inclisiran
• Dosage Form: Injection, Solution
• Route of Administration: SUBCUTANEOUS
• Marketing Start Date: 2021-12-22
• Marketing Category: NDA /
• Application Number: NDA214012
• Labeler Name: Novartis Pharmaceuticals Corporation
• Substance Name: INCLISIRAN SODIUM
• Active Ingredient Strength: 284 mg/1.5mL
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 0078-1000-60

1 SYRINGE, GLASS in 1 CARTON (0078-1000-60) > 1.5 mL in 1 SYRINGE, GLASS

• Marketing Start Date: 2021-12-22
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details